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Abstract
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The loss and recovery of muscle mass and function following injury and during rehabilitation
varies among individuals. While recent expression profiling studies have illustrated transcriptomic
responses to muscle disuse and remodeling, how these changes contribute to the physiological
responses are not clear. In this study, we quantified the effects of immobilization and subsequent
rehabilitation training on muscle size and identified molecular pathways associated with muscle
responsiveness in an orthopaedic patient cohort study. The injured leg of 16 individuals with ankle
injury was immobilized for a minimum of 4 weeks, followed by a 6-week rehabilitation program.
The maximal cross-sectional area (CSA) of the medial gastrocnemius muscle of the immobilized
and control legs were determined by T1-weighted axial MRI images. Genome-wide mRNA
profiling data were used to identify molecular signatures that distinguish the patients who
responded to immobilization and rehabilitation and those who were considered minimal
responders. RESULTS: Using 6% change as the threshold to define responsiveness, a greater
degree of changes in muscle size was noted in high responders (−14.9 ± 3.6%) compared to low
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responders (0.1 ± 0.0%) during immobilization. In addition, a greater degree of changes in muscle
size was observed in high responders (20.5 ± 3.2%) compared to low responders (2.5 ± 0.9%) at 6week rehabilitation. Microarray analysis showed a higher number of genes differentially expressed
in the responders compared to low responders in general; with more expression changes observed
at the acute stage of rehabilitation in both groups. Pathways analysis revealed top molecular
pathways differentially affected in the groups, including genes involved in mitochondrial function,
protein turn over, integrin signaling and inflammation. This study confirmed the extent of muscle
atrophy due to immobilization and recovery by exercise training is associated with distinct
remodeling signature, which can potentially be used for evaluating and predicting clinical
outcomes.
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Introduction
Skeletal muscle remodeling occurs in response to physiological stimuli, affecting both
muscle size and functional properties. Skeletal muscle atrophy occurs during muscle disuse,
such as immobilization, mircrogravity as well as bed rest. The reported decrease in muscle
size during 2 to 6 weeks of disuse ranges from 0 to 26% depending on the duration of
disuse, the modality used and the muscles studied [1–4].

Author Manuscript

Many molecular processes have been reported to be involved in muscle atrophy, including
pathways affecting inflammation, mitochondrial function, protein turn over, extracellular
matrix remodeling and autophagy [5–10]. Although considerable attention has focused on
muscle atrophy with disuse, less attention has centered on muscle recovery. A small number
of studies performed in healthy volunteers subjected to either unloading or cast
immobilization, reported that the recovery time following disuse is approximately equal to
the duration of disuse. Less consensus exists on the rate of recovery in patient populations.
Most of the studies show that recovery following an orthopaedic injury is often incomplete
despite intense rehabilitation interventions [11–14]. In addition, considerable interindividual variation in the response to rehabilitation treatment exists, leading investigators to
group patients into “responders” and “non-responders” [15,16].

Author Manuscript

The development of effective therapeutic interventions necessitates an in depth
understanding of molecular mechanisms mediating muscle atrophy and the subsequent
recovery. Disuse causes significant muscle remodeling, including a loss of myofibrillar
proteins, a shift in metabolic profile from slow to fast, and vascular and neural alterations
[5,17,18]. The rapid loss in myofibrillar protein during disuse is mediated by a transient
decrease in protein synthesis, followed by an increase in protein degradation, resulting in net
protein loss [5,19–21]. Gene regulating protein turnover including heat shock proteins and
genes involved in protein degradation have been reported as one of the major pathways
involved in muscle atrophy [22–25].
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There is strong evidence that the ubiquitin-proteasome proteolytic pathway is the primary
system responsible for the breakdown of long-lived skeletal muscle proteins [8,26,27] and
that the ubiquitin protein ligases E3 (e.g. atrogin-1 or FBX32) define much of its specificity
[28–30]. In addition, genes involved in mitochondrial functions have been reported to be
severely affected in different conditions leading to muscle atrophy including immobilization,
unloading, space flight and cancer cachexia [5,23,31–35] although the direct trigger of the
changes is not clear.

Author Manuscript

Conversely, increase in neuromuscular activity (e.g. during high resistance training) induces
an increase in protein content, myonuclear number, myofiber size and muscle strength;
created in part via a cycle of injury and muscle regeneration and remodeling. Muscle
regeneration is a complex process, requiring the coordinated interaction between myogenic
progenitor cells or satellite cells, growth factors, protein synthesis, cytokines, capillary
morphogenesis, and the extracellular matrix [36]. Previous studies showed genes and
molecular pathways involved in energy metabolism, protein ubiquitination, extracellular
matrix remodeling, vasculature remodeling and inflammation are involved in muscle
responses to resistant training [22,25,37–43].
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Although considerable progress has been made towards defining the pathophysiology of
muscle regeneration and hypertrophy, it should be pointed out that most of our knowledge
today is based on information extrapolated from animal models and exercise training studies
in healthy and aged individuals. Few studies have specifically investigated the
pathophysiology of muscle remodeling and rehabilitation in patient populations. In this
study, we hypothesize that the key molecular pathways involved in muscle remodeling
during atrophy and rehabilitation are differentially activated in “responders” versus “nonresponders”. In this study, we temporal expression profiled muscle biopsies obtained from
two groups of orthopaedic patients that showed different responsiveness to cast
immobilization and a standardized rehabilitation intervention. The expression profiles of the
two groups were compared to identify molecular signatures that distinguish responders from
non-responders.

Methods
Participants

Author Manuscript

Twenty-four individuals (13 men, 11 women; mean age 26.7 ± 8.3 years) participated in this
study (Table 1). Of these 24 subjects, 16 participated in all of the tests and measures at all of
the four time points (see next paragraph). These 16 were included in the gene profiling
portion of the study. All subjects had sustained an injury to the lower leg that was treated
conservatively (4–6 weeks of immobilization). Following immobilization, each subject
completed 6 weeks of a structured rehabilitation program focused on progressive resistance
training of the ankle plantarflexor musculature as previously described [14]. The study was
approved by the institutional review board at the University of Florida and Children’s
National Medical Center. All subjects provided their signed and informed consent before
participating in the study.
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Magnetic resonance imaging (MRI) was performed on either a 1.5T (Signa, GE Medical
Systems) or 3.0T (Achieva, Philips Medical Systems) whole-body scanner at the following
time points: at the end of the 4–6 week immobilization period for a baseline measure, (prerehab), 3 weeks into the rehabilitation program (mid-rehab), following the 6 week
rehabilitation program, (post-rehab), and 6 months after immobilization (control). Subjects
were placed in a supine position with their lower leg positioned in either a lower-extremity
quadrature coil (1.5T) or an 8-channel sensitivity encoding, receive-only extremity coil
(3.0T). MRI was done on both lower legs for each subject covering the area from the tibial
tuberosity to the proximal Achilles tendon. Three-dimensional transaxial fat-suppressed
gradient echo images were acquired with an optimized field of view (12–16 cm2), matrix
231 × 231 pixels, and a 7mm slice thickness. Acquisition parameters were TR/TE=17.6/3.3
ms and flip angle=10° at 1.5T, and TR/TE=17.5/1.9 ms and flip angle=20° at 3.0T.
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The head of the medial gastrocnemius was manually outlined using OsiriX Imaging
Software, an open-source software. The axial image with the largest cross-sectional area
(CSA) in the series was identified. The average of three consecutive slices (the slice with the
greatest CSA, the slice below, and the slice above) was calculated to determine the maximal
CSA (CSAmax) for the medial gastrocnemius. Based on the changes in CSAmax the
subjects were grouped in high or low responders. Subjects with changes in CSAmax > 6%
were categorized as a high response subject, <6% is defined as a low response subject. The
cut-off value of 6% was selected by taking into account the reproducibility of the MR
CSAmax measurements and the amount of atrophy that was considered clinically
meaningful [14].
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All statistical analyses were performed with SPSS for Windows, Version 16.0 (SPSS Inc.,
Chicago, IL). Independent t-tests were used to compare the maximal CSA between different
groups. A significance level of p<0.05 was used for all comparisons. Data were presented as
mean ± SEM.
Muscle biopsy
A total of 4 biopsies were obtained at different time points (pre-rehab, mid-rehab, post-rehab
and control) from the medial gastrocnemius. Skin was first sterilized and anesthetized with a
2% lidocaine hydrochloride solution. The orthopaedic surgeon then made a small incision
(less than 1/4″) in the skin and fascia, a sterile biopsy needle was inserted, and a small
amount of tissue was removed. All biopsy tissue was snap frozen in liquid nitrogen and
stored at −80°C for further analysis.

Author Manuscript

Expression profiling
Affymetrix Human Genome U133 Plus 2.0 microarrays containing approximately 47,000
transcripts were used for the expression profiling experiment. Standard procedures including
total RNA isolation, cDNA synthesis, cRNA labeling, microarray hybridization and image
acquisition were done as described in the manufacturer’s protocol and our previous
publications [44,45]. Briefly, total RNA samples were isolated with TRIzol reagent
(Invitrogen) then purified with RNeasy MinElute Cleanup Kit (Qiagen) following the
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manufacturer’s protocol. Two hundred nanograms of total RNA from each sample were
reverse-transcribed to double-stranded cDNA followed by in vitro cRNA synthesis using
one-cycle target labeling and control reagents and protocol (Affymetrix). Biotin-labeled
cRNA was then purified using GeneChip® Sample Cleanup Module (Affymetrix) and
fragmented randomly prior to hybridizing to the microarrays over night. Each array was
washed and stained using the Affymetrix Fluidics Station 450, and then scanned using the
GeneChip® Scanner 3000. The quality control criteria developed at Children’s National
Medical Center Microarray Center for each array were followed [46].
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The array image analysis was performed using Microarray Suite 5.0 (MAS 5.0) (Affymetrix,
CA). After the absolute analysis, the gene expression values were imported into GeneSpring
11.0 (Silicon Genetics) for data filtering and statistical analysis. First, genes were filtered
with numbers of present calls across the arrays analyzed. Genes with at least 7 present calls
(detected by more than 10% of the arrays) were selected for statistical analysis. We
identified 32,766 probe sets met this filtering criterion. In GeneSpring, paired t-test was
performed and probe sets showing significant (p<0.05) expression changes were retained for
pathway analysis.
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To investigate molecular networks and pathways associated with gene lists in this study,
Ingenuity Pathway Analysis (IPA) (Ingenuity Systems) was used to identify gene
interactions and to prioritize molecular pathways differentially affected in different groups.
The significance of the association between the genes in each dataset and the canonical
pathway was determined by Fischer’s exact test. The p-values were calculated to determine
the probability of the association between the genes and the pathways. All profiles are made
publicly accessible via NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/) #GSE45462.
Hierarchical clustering was performed using GeneSpring software to visualize transcripts
showing coordinated regulation as a function of time.

Results
Impact of immobilization and rehabilitation on maximum muscle CSA

Author Manuscript

Overall, CSAmax of the medial gastrocnemius in the injured legs at pre-rehab was 9.6
± 2.9% smaller compared to that of the un-injured legs. At mid-rehab the CSAmax had
increased in size to being 6.3 ± 2.5% less than the un-injured legs (p<0.05). By the postrehab time point (6 weeks), the CSAmax had returned to a level comparable to that of the
un-injured leg (n=24, p>0.05, Figure 1A). We then further examined subjects that were
included in the expression profiling study (n=16) and stratified them into high responders
and low responders based on the extent of muscle atrophy during immobilization as well as
the extent of muscle recovery during and after rehabilitation. High responders were defined
as subjects who demonstrated more than 6% change in muscle size. Figures 1B and 1C
illustrate the morphological changes for both groups separately, with low responders (n=4)
showing relatively little atrophy (0.1 ± 0.0%) after the immobilization and high responders
(n=8) showing a 14.9 ± 3.6% decrease in muscle size (Figure 1B, p<0.05). Conversely, in
response to the rehabilitation intervention high responders showed a 20.5 ± 3.2% increase
(n=9) in muscle size, while low responders showed little recovery (2.5 ± 0.9% increase, n=7)
(Figure 1C, p<0.05). It is worth pointing out that, in general, low responders for changes in
Biomed Genet Genom. Author manuscript; available in PMC 2017 August 23.
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muscle size with immobilization were also low responders for rehabilitation, and high
responders for immobilization were also high responders for rehabilitation. Figure 2
contains MRIs of the lower leg of one subject who responded to the immobilization and
rehabilitation training, which demonstrate the change in muscle size over the four different
time points.
Global gene expression changes during immobilization and rehabilitation
To identify genes differentially expressed during immobilization (pre-rehab) and
rehabilitation (mid- and post-rehab), we performed expression profiling using Affymetrix
Human Genome U133 Plus 2.0 microarrays containing approximately 47,000 transcripts.

Author Manuscript
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Filtered by Affymetrix “present calls”, transcripts corresponding to 32,766 probe sets were
defined as detected by the arrays and retained for further analysis. Genes differentially
regulated at each time point compared to the control time point of the same subjects were
identified using paired t-tests. Note the control biopsy of each individual was collected 6
months after the completion of the rehabilitation to assess the baseline gene expression. In
the high response group, 3313 probe sets were differentially expressed between the prerehab and the control time points, while changes of only 1710 probe sets were detected in
the low response group (Figure 3). At the mid-rehab time point, 4124 and 3138 probe sets
showed significant changes in the high and low response groups, respectively. At the postrehab time point, 2627 and 1693 probe sets showed significant changes in the high and low
response groups, respectively. The data showed an overall higher numbers of genes
differentially expressed in the responders compared to non-responders at both the
immobilization and the rehabilitation stages. Interestingly more expression changes were
identified at the mid-rehab time points in both groups in comparison to the pre- and postrehab time points.
Distinct molecular signatures during immobilization and rehabilitation between the high
and low response groups
To identify major molecular pathways affected in the two groups during the immobilization
and rehabilitation, the probe sets showed significant changes were further analyzed using
Ingenuity Pathway Analysis (IPA) and hierarchical clustering analysis.
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Table 2 shows the top 5 ranked canonical pathways identified by IPA. Please note that while
the names of the pathways often directly indicate their biological functions, tissue-specific
roles of the changes were not taken into consideration when the pathways were constructed
by the IPA, therefore a cancer related pathway may indicate a pathway involved in
regulating cell growth and survival in skeletal muscles instead of cancer.
Subjects who responded to immobilization by reducing muscle mass significantly showed
changes in pathways involving in mitochondrial function, protein turnover and BMP
signaling (Table 2). Individual genes in each of the pathways are listed in supplemental table
1 (pre-rehab vs. control). The top ranked pathways in subjects who showed low
responsiveness to the immobilization and rehabilitation were different from those of the high
responders. The top 5 pathways include genes involving GM-CSF Signaling, Protein
ubiquitination pathway, glioma signaling, FAK Signaling and CXCR4 Signaling (Table 2).
Biomed Genet Genom. Author manuscript; available in PMC 2017 August 23.
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Individual genes in each of the pathways are listed in supplemental table 2 (pre-rehab vs.
control). While the only shared pathway between the two groups of subjects is the protein
ubiquitination pathway, only a small number of genes in the pathway (8 transcripts) were
shared between the two groups while others are different members involved in the pathway.
In addition, while the ubiquitination pathway was highly ranked in the high response group
during both mid- and post-rehabilitation, it was only highly ranked in the low response
group following immobilization.
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To visualize the expression pattern of the genes involved in ubiquitination pathway, we
selected all the genes that were differentially expressed in either group at any of the 3 time
points, followed by hierarchical clustering analysis. The analysis clustered genes with
similar expression patterns at all time points therefore genes clustered together shared
similar expression changes in each group. In contrast to the mitochondrial genes, figure 4A
showed that many genes in the ubiquitination pathway were differentially expressed between
the high and low responder groups. A cluster of genes that showed obvious opposite changes
were circled (Figure 4A) and listed in supplemental table 3. One third (15/44) of the
transcripts in the cluster belonged to heat shock protein family and one third (16/44)
functioned in the ubiquitin proteasome pathways. The data showed a generally lower
expression of these genes in the high responder group during the rehabilitation period
although only the changes at the mid- rehab time point were significant (Table S3).
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Among the pathways that are highly ranked during both mid- and post- rehabilitation, genes
involved in integrin signaling were differentially expressed in both high and low response
groups. While there are more genes in this category differentially expressed in the high
responding group, there is no obvious difference in terms of expression pattern when
visualized by hierarchical cluster analysis. The data suggested a stronger activation of the
integrin signaling in the high responders while the pathway was activated in both group.
This is supported by that the activation of the ILK signaling and the higher fold changes
only in the high response group (Table S1 and S2).
Although many of the pathways were shared between the groups with either obvious or
subtle differences, some pathways showed specific activation in one of the groups only.
Pathways involved in antigen presentation pathway and Fcγ receptor-mediated phagocytosis
in macrophages and monocytes were highly ranked at the acute stage of the rehabilitation in
the high response group only, while actin cytoskeleton signaling pathway was activated in
the low response group during the same stage of the rehabilitation (Table 1).
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Mitochondrial genes are highly regulated during immobilization and rehabilitation in
muscles of the high responders
During immobilization the 3 top ranked pathways of the responders contain genes involved
in mitochondrial functions. The majority of the genes in the pathways were down-regulated
in muscles during immobilization. These genes include those involved in oxidative
phosphorylation, ubiquinone biosynthesis and mitochondrial membrane proteins (Table 2
and Table S1). To visualize the expression patterns of these genes in the high and low
responder groups, we performed hierarchical clustering analysis of the genes that were
differentially expressed at any one of the 3 time points of both groups. Figure 4B showed
Biomed Genet Genom. Author manuscript; available in PMC 2017 August 23.
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that most of the genes were down-regulated in both groups during immobilization, however
the changes in the low response groups was milder. In addition, the expression changes of
the genes returned toward baseline faster in the low responders during the early
rehabilitation stage (Figure 4B).
In the low responder group, genes involved in mitochondrial function were not highly
ranked at the pre-rehab time point but some of the mitochondrial pathways moved up to the
top ranked functional groups during the mid- and post-rehab time points. The data indicated
that genes involved in mitochondrial functions were significantly down-regulated in the high
responders while the mitochondrial changes were delayed in the low responder group and to
a less extent in general. Instead, genes involved in AKT signaling pathways were activated
in the muscles of low responders (Table S2).
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Discussion
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Expression profiling has been used to examine transcriptomic changes in response to muscle
immobilization and exercise training [22,24,25,39,47–50]. While individual studies of
transcriptomic responses to conditions leading to muscle remodeling have been conducted,
to our knowledge this is the first longitudinal study investigating both immobilization and
rehabilitation stages in a patient population. Our data showed an overall higher numbers of
genes differentially expressed in the responders compared to non-responders at both the
immobilization and the rehabilitation stages, likely to directly reflect the activities of muscle
remodeling. Interestingly more expression changes at the acute stage of rehabilitation in
both groups were identified in comparison to those at the immobilization and chronic stages.
When the differentially expressed genes were analyzed using IPA, distinct pathways were
activated at each stage without major overlap between the responder and non-responder
groups. The findings suggest that the remodeling is most active at the beginning of the
rehabilitation. Instead of simply reversing the molecular changes due to muscle
immobilization, additional pathways were activated to actively regain the lost muscles. In
addition, the pathways involved in the whole process from the immobilization to
rehabilitation are quite different between the high responder group and the low responder
group, suggesting different molecular pathways were involved in the two groups of patients.
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Based on genome-wide mRNA expression data, specific molecular signatures associated
with high responsiveness and low responsiveness to immobilization and rehabilitation were
identified. Not surprisingly, the expression of more transcripts was changed in the high
responders, indicating that the responsiveness involved transcriptional regulation. Pathways
analyses showed that distinct molecular pathways were affected in the two groups. During
immobilization, the top-ranked molecular pathways affected in the high responders are
involved in mitochondrial functions, protein turnover and BMP signaling. The downregulation of mitochondrial genes has been reported previously to be a major change in
muscle atrophy caused by different conditions including immobilization, unloading, space
flight and cancer cachexia [5,23,31–35]. Genes regulating protein turnover including heat
shock proteins and genes involved in protein degradation have also been reported as one of
the major pathways involved in muscle atrophy [22–25]. Our findings suggest that the
pathways and genes involved in mitochondrial function and protein degradation are critical
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responses involved in muscle atrophy. The BMP signaling pathway identified by IAP was
not reported as a major molecular signature of responses to immobilization previously,
although it is involved in limb development and muscle regeneration [51]. In this study, the
two most up-regulated genes were follistatin (2.5 fold) and noggin (2.1 fold). Follistatin is a
known positive regulator of muscle mass. It can inhibit myostatin activity by protein-protein
interaction and promote muscle growth in vivo [52]. Noggin is an inhibitor of BMP
signaling which has been shown critical to suppress premature differentiation of satellite
cells [53]. Up-regulation of the noggin can potentially suppress the BMP signaling and
promote regeneration. The findings suggest that these changes are likely to be compensatory
responses as part of the effort to maintain the muscle mass, which might be critical for rapid
recovery in the high responders when the rehabilitation starts.

Author Manuscript
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The only shared pathway in both high and low responder groups was the protein
ubiquitination pathway. Interestingly, while the pathway was affected significantly in both
groups, only 8 genes were actually shared between the groups. When all the genes that were
differentially expressed in either group were grouped together and analyzed by hierarchical
clustering analysis, we showed that a subgroup of the genes consisted of heat shock proteins
and genes involved in protein degradations was differentially regulated. These genes were
down-regulated in the high responders but not changed in the low responders. Both the heat
shock proteins and the genes involved in protein degradation have been shown critical to
muscle regeneration and remodeling. Several heat shock proteins including HSP70 and
HSP90 has been shown to be up-regulated in muscles in response to exercise and can
improve muscle repair [54–59]. One of the HSP40 proteins, DNAJB6, was discovered as the
causative gene of the limb-girdle muscular dystrophy type 1E [60]. While the role of HSP40
and HSP105 in muscle atrophy is not clear, several studies showed that these heat shock
proteins can suppress the aggregation of truncated proteins with expanded CAG repeats and
cell toxicity in neurodegenerative diseases likely by increasing in target protein degradation
via the ubiquitin-proteasome system [61–63]. While the cause of the lower expression level
of the heat shock proteins in the high responder group is not clear, this is an interesting
molecular signature for the high responders and likely contributes to their susceptibility to
more severe muscle atrophy during immobilization.
In the low response group, the 4 activated pathways that were not shared with the high
response group were all centered at AKT/PI3K signaling which plays critical role in
regulating cell proliferation, survival and metabolism. The PI3K/AKT/mTOR signaling
pathway is critically involved in muscle survival and remodeling. Its role in muscle atrophy
and hypertrophy in response to various stimuli has been extensively studied.
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The activation of AKT signaling and its downstream targets glycogen synthase kinase- 3beta
(GSK3beta), mTOR and Foxo1 have been shown to promote muscle hypertrophy and
attenuate muscle atrophy [25,28,64,65]. While the AKT1 is the most studied form, the role
of AKT2 and 3 in the muscles is less known. The biological significance of these signatures
in the low responders needs to be further investigated.
Our study showed that the high responders and low responders have distinct molecular
signatures during the rehabilitation process. During the acute phase of the rehabilitation the
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most highly ranked pathways in the high responders are pathways known to be involved in
muscle responses to resistance training, including genes in the integrin and ILK signaling
pathways as well as inflammation. Integrin and ILK signaling pathways have been shown to
play critical roles in both cardiac and skeletal muscle hypertrophy [22,37,38,40,41,43]. In
our study, 6 integrins were up-regulated in the high responder group with most of them
previously reported to be involved in angiogenesis or muscle differentiation [66–72]. One of
the integrins, integrin alpha 4 (2.3 fold), was reported to mediate BMP activated ILK
signaling. Integrin-linked kinase (ILK) is a serine/threonine kinase and scaffolding protein
[73]. ILK has been implicated in cancer cell growth and survival by modulating AKT
signaling.

Author Manuscript

Skeletal muscle expresses high levels of ILK at myotendinous junctions and costameres,
which stabilizes myotendinous junctions and protects muscle from stress-induced damage
[74]. Previous studies also showed that ILK functions as a molecular adaptor protein linking
integrins to the actin cytoskeleton and regulating actin polymerization [75–77]. Mice lacking
ILK develop phenotypes resembling those seen in humans and mice lacking the alpha 7integrin subunit, which lead to muscular dystrophy [78]. In addition to the roles of integrin
and ILK signaling in skeletal muscle cells, some of the integrins identified are known to play
a critical role in angiogenesis, which is a major process affecting skeletal muscle remodeling
during muscle repair and hypertrophy [76,79,80]. In addition, these pathways and the protein
ubiquitination pathways have been shown to be up-regulated in muscles in response to
exercise. Our findings showed that the activation of integrin and ILK pathways, indicative of
active muscle remodeling and angiogenesis, is a molecular signature in the high responder
group only. An attenuated response was observed in the low responder group, suggesting a
weaker muscle remodeling response.
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Inflammation including cellular infiltration and specific cytokine productions has been
shown to play key roles in muscle hypertrophy in response to acute exercise [39,81–83]. In
addition, it is known that inflammation plays a critical role in muscle regeneration [84,85].
In our study, we identified genes and pathways involved in inflammation in the high
responder group only at the mid-rehab stage. The inflammatory responses were not detected
during the later phase of rehabilitation as expected. Therefore, the activation of
inflammatory pathways at the beginning of rehabilitation appeared to be unique molecular
signature of the high responder group.
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While genes involved in integrin signaling were also ranked in the top 5 of the low
responders during rehabilitation, the other four pathways created a distinct signature of the
molecular responses of the low responders during the acute phase of training. Instead of
inflammatory and extracellular matrix remodeling, the signature indicated a continuation of
mitochondrial dysfunction in these subjects. This mitochondrial defect remained at the top
of all pathways affected even at the later stage of rehabilitation suggesting the defect in
mitochondrial function and energy production may play a major role in the low
responsiveness in these subjects. In addition, the results of the study showed that changes of
these molecular pathways can potentially be used as molecular markers to determine the
effects of rehabilitation and evaluate the patients’ responsiveness to the training.
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Longitudinal studies of muscle dysfunction with disuse in healthy subjects indicate the
extent of muscle atrophy is muscle specific. In the present study, 4 weeks of cast
immobilization induced a decrease in plantarflexor muscle size, which is consistent with the
literature [2,86]. Interestingly, the adults in this study showed a range of variability in their
responsiveness to immobilization and training. Factors not under investigation in the present
study have been demonstrated to affect the degree of muscle adaptations, such as age, sex,
diet, activities of daily living, motivation, and previous training status [87,88]. Even when
the above factors are controlled, the results of clinical studies still demonstrated considerable
variation in the extent of muscle adaptations [89,90]. In addition, the compliance of the
subjects with the rehabilitation program may also be a factor in how skeletal muscle tissue
responds [91]. It may be useful to record the factors determining the adherence to the
rehabilitation programs to assess or explain the differential responses/outcomes. Therefore,
more information is needed to help define what factors substantially influence the intersubject variation in muscular adaption.

Conclusion

Author Manuscript

Expression analysis based on the patients’ responsiveness to immobilization and
rehabilitation yielded two major findings. First, training outcomes were positively correlated
with the extent of transcriptomic changes. Individuals showed less adaptation to exercise
also showed less gene expression changes in the muscle biopsies. Second, the molecular
signatures of individuals who showed different responsiveness to immobilization and
rehabilitation were distinct such as pathways involved in mitochondrial functions, protein
turn over and muscle remodeling. These results suggest that these transcriptomic signatures
of muscle gene expression may have predictive value in training outcomes in adults
receiving rehabilitation following atrophy of skeletal muscle from disuse.
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Figure 1.
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Percentage changes of maximal CSA (CSAmax) for the medial gastrocnemius from A) all
the subjects at the first three time points; *Significantly different compared with control
average CSA from the contralateral (uninvolved) legs. B) subjects included in the expression
profiling study at pre-rehab in comparison with control average CSA from the contralateral
(uninvolved) legs; # Significantly different compared with low responders (P<0.05). C)
subjects included in the expression profiling study after 6-week rehabilitation program (postrehab) in comparison with pre-rehab from the same (involved) sides. # Significantly
different compared with low responders (P<0.05). Dataare presented as mean±SEM.
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Figure 2.

Representative transaxial proton T1-weighted MRIs of the lower leg from different time
points of one patient in the high response group. (A) pre-rehab, (B) mid-rehab, (C) postrehab and (D) control.
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Figure 3.

Patients in the high response group showed greater number of gene expression changes
during immobilization (pre-rehab), early rehabilitation (3 weeks, mid-rehab) and late
rehabilitation (6 weeks, post-rehab) stages. More expression changes during the acute stage
of rehabilitation in both groups were identified in comparison to the other stages.
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Figure 4.

Distinct molecular signatures during immobilization and rehabilitation between subjects in
the high and low response groups were identified by hierarchical clustering analysis During
immobilization and rehabilitation periods, genes involved inmitochondrial functions were
affected more in muscles of the high responders compared to those of low responders. B. A
subset of stress response proteins was down-regulated in muscles of the high responders.
Color code: yellow: baseline; red: up-regulated; blue: down-regulated. H:high responder;
L:low responder; CON: control time point; IMM: pre- rehab/immobilization; AR, 3w: midrehab/3 weeks acute phase of rehabilitation; CR, 6w: post-rehab/6 weeks chronic phase of
rehabilitation.
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calcaneal fracture

fibular fracture

metatarsal fracture

Unknown

metatarsal fracture

fibular fracture

fibular fracture

metatarsal fracture

ankle sprain/avulsion of ATF on tibia

metatarsal fracture

fibular fracture

fibular fracture

Injury Type
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Table 2

Author Manuscript

Top 5 canonical pathways affected in subjects during immobilization and rehabilitation. Number of significant
probes in each pathway is included in the parentheses
Immobilization

Rehabilitation

High Responders

Low Responders

Oxidative Phosphorylation (66)

GM-CSF Signaling (15)

Mitochondrial Dysfunction (55)

Protein Ubiquitination Pathway (40)

Ubiquinone Biosynthesis (33)

Glioma Signaling (18)

Author Manuscript

Protein Ubiquitination Pathway (64)

FAK Signaling (17)

BMP signaling pathway (25)

CXCR4 Signaling (24)

High Responders

Low Responders

Protein Ubiquitination Pathway (84)

Mitochondrial Dysfunction (45)

Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes (31)

Oxidative Phosphorylation (44)

ILK Signaling (50)

Actin Cytoskeleton Signaling (55)

Integrin Signaling (51)

Integrin Signaling (49)

Acute phase

Antigen Presentation Pathway (15)

Ubiquinone Biosynthesis (22)

Rehabilitation

High Responders

Low Responders

Chronic Phase

Molecular Mechanisms of Cancer (58)

Mitochondrial Dysfunction (23)

ILK Signaling (35)

Integrin Signaling (30)

Clathrin-mediated Endocytosis Signaling (31)

Ephrin Receptor Signaling (24)

Integrin Signaling (35)

HMGB1 Signaling (16)

Protein Ubiquitination Pathway (43)

Rac Signaling (17)

Author Manuscript
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